JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
UPDATE: JMP Securities Starts CTI BioPharma (CTIC) at Market Outperform
-
Palomar Holdings Inc. (PLMR) Prices 1M Share Common Offering at $82/Sh
-
Palomar Holdings, Inc. Announces Pricing of Public Offering of Common Stock
-
TELA Bio Inc. (TELA) Announces Proposed 3M Common Share Offering
-
TELA Bio Announces Proposed Public Offering of Common Stock
-
TELA Bio Announces Proposed Public Offering of Common Stock
-
OrthoPediatrics Corp. Announces Closing of Offering of Common Stock
-
OrthoPediatrics Corp. Announces Closing of Offering of Common Stock
-
LiveXLive Media (LIVX) PT Raised to $5 at JMP Securities
-
OrthoPediatrics (KIDS) Prices 1.6M Share Common Offering at $47/Sh
-
OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock
-
OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock
-
Incyte Investor Conference Update
-
Syros Announces Change to Presentation Time at JMP Securities Hematology and Oncology Forum
-
Harpoon Therapeutics Updates Information for its Participation in Two Upcoming Virtual Conferences
-
Harpoon Therapeutics Updates Information for its Participation in Two Upcoming Virtual Conferences
-
Office Properties Income Trust Prices $150 Million of 6.375% Senior Notes Due 2050
-
Demandbase Acquires Engagio
-
Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum
-
Syros to Present Virtually at JMP Securities Hematology and Oncology Forum
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Kura Oncology to Participate in JMP Securities Hematology & Oncology Forum
-
Precigen to Participate in Upcoming JMP Securities Hematology and Oncology Forum
-
Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Forum
-
Vroom (VRM) IPO Opens 83% Higher
-
Demandbase Named A Leader Among Account-Based Marketing Platforms
-
UPDATE: Vroom Inc. (VRM) Prices 21.25M Share IPO at $22/Sh
-
Vroom Announces Pricing of Initial Public Offering
-
Lemonade Announces Filing of Registration Statement for Proposed Initial Public Offering
-
JMP Securities Reinstates Minerva Neurosciences (NERV) at Market Outperform
-
ZoomInfo Technologies (ZI) IPO Opens 90% Higher
-
UPDATE: ZoomInfo Technologies Inc. (ZI) Prices 44.5M Class A Share IPO at $21/Sh
-
ZoomInfo Announces Pricing of its Initial Public Offering
-
Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
-
Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
-
Incyte to Present at Upcoming Investor Conferences
-
Vroom Announces Launch of Initial Public Offering
-
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
-
BioCryst Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants
-
argenx announces closing of global offering
-
argenx announces closing of global offering
-
Baudax Bio Secures $50 Million Credit Facility
-
Baudax Bio Secures $50 Million Credit Facility
-
Hurricanes may cause more pain for pandemic-hit insurers
-
Allogene (ALLO) PT Raised to $53 at JMP Securities
-
TPG RE Finance Trust (TRTX) PT Raised to $10 at JMP Securities
-
Demandbase Extends Leadership Team To Drive Product Vision
-
Fiverr International (FVRR) Prices 2M Share Follow-On Offering at $60/Sh
-
argenx announces full exercise of underwriters’ option to purchase additional ADSs

